Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EVOLVA BIOTECH A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Bankruptcy risk for industry   1.2% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2%   Bankruptcy risk   0.0% 1.6% 2.9% 4.5% 18.8% 18.3% 11.6% 9.6%   Credit score (0-100)   0 76 60 48 8 8 19 25   Credit rating   N/A A BBB BBB B B BB BB   Credit limit (kDKK)   0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 59,908 0 0 0 0 0 0   Gross profit   0.0 41,876 49,857 2,917 639 -116 0.0 0.0   EBITDA   0.0 5,890 5,991 110 -200 -116 0.0 0.0   EBIT   0.0 182 187 110 -200 -116 0.0 0.0   Pre-tax profit (PTP)   0.0 -619.5 -724.5 241.4 -187.0 -196.8 0.0 0.0   Net earnings   0.0 -619.5 -724.5 241.4 -187.0 -196.8 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -620 -725 241 -187 -197 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Tangible assets total   0.0 18,191 3,739 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 7,246 6,521 6,762 6,575 6,379 2,067 2,067   Interest-bearing liabilities   0.0 11,674 838 1.1 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0.0 31,564 21,049 8,057 6,578 6,486 2,067 2,067   Net Debt   0.0 5,974 -2,816 -96.5 -1,190 -100 -2,067 -2,067     See the entire balance sheet 1000.0 Volume  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 59,908 0 0 0 0 0 0   Net sales growth   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 41,876 49,857 2,917 639 -116 0.0 0.0   Gross profit growth   0.0% 0.0% 19.1% -94.1% -78.1% 0.0% 0.0% 0.0%   Employees   0 56 0 1 1 0 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 31,564 21,049 8,057 6,578 6,486 2,067 2,067   Balance sheet change%   0.0% 0.0% -33.3% -61.7% -18.4% -1.4% -68.1% 0.0%   Added value   0.0 5,889.7 5,991.2 109.9 -199.7 -116.4 0.0 0.0   Added value %   0.0% 9.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 12,483 -20,255 -3,739 0 0 0 0   Net sales trend   0.0 0.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A EBITDA %   0.0% 9.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.4% 0.4% 3.8% -31.3% 100.2% 0.0% 0.0%   Net Earnings %   0.0% -1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 8.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% -1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 1.3% 1.3% 2.0% -1.7% -1.2% 0.0% 0.0%   ROI %   0.0% 1.7% 2.2% 4.1% -1.9% -1.2% 0.0% 0.0%   ROE %   0.0% -8.6% -10.5% 3.6% -2.8% -3.0% 0.0% 0.0%   1000.0 Solidity  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Equity ratio %   0.0% 23.0% 31.0% 83.9% 100.0% 98.3% 100.0% 100.0%   Relative indebtedness %   0.0% 40.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 31.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 101.4% -47.0% -87.8% 595.9% 86.0% 0.0% 0.0%   Gearing %   0.0% 161.1% 12.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 17.5% 17.2% 11.0% 11,067.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Quick Ratio   0.0 0.8 1.2 6.2 2,890.0 60.5 0.0 0.0   Current Ratio   0.0 0.8 1.2 6.2 2,890.0 60.5 0.0 0.0   Cash and cash equivalent   0.0 5,700.5 3,653.9 97.6 1,189.9 100.2 0.0 0.0   1000.0 Capital use efficiency  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 12.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 -1,913.1 2,781.7 6,756.4 6,575.4 6,378.6 0.0 0.0   Net working capital %   0.0% -3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2015 N/A 2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales / employee   0 1,070 0 0 0 0 0 0   Added value / employee   0 105 0 110 -200 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 105 0 110 -200 0 0 0   EBIT / employee   0 3 0 110 -200 0 0 0   Net earnings / employee   0 -11 0 241 -187 0 0 0